17 Nov 2016 10:39
Sinclair Pharma plc
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them (in accordance with the Market Abuse Regulations)
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Alan Olby | ||||
2. | Reason for the notification | |||||
a. | Position/status | Chief Financial Officer | ||||
b. | Initial notification /Amendment | Initial Announcement | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Sinclair Pharma plc | ||||
b. | LEI | |||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 1 pence each in Sinclair Pharma plc
GB0033856740 | ||||
b. | Nature of the transaction |
Exercise of Replacement Options
| ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price
|
N/A
| ||||
e. | Date of the transaction | 2016-11-14 | ||||
f. | Place of the transaction | London Stock Exchange
| ||||